These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10747881)

  • 21. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of the core structure of alpha-synuclein filaments.
    Miake H; Mizusawa H; Iwatsubo T; Hasegawa M
    J Biol Chem; 2002 May; 277(21):19213-9. PubMed ID: 11893734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies.
    Ihara M; Tomimoto H; Kitayama H; Morioka Y; Akiguchi I; Shibasaki H; Noda M; Kinoshita M
    J Biol Chem; 2003 Jun; 278(26):24095-102. PubMed ID: 12695511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.
    Hodara R; Norris EH; Giasson BI; Mishizen-Eberz AJ; Lynch DR; Lee VM; Ischiropoulos H
    J Biol Chem; 2004 Nov; 279(46):47746-53. PubMed ID: 15364911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell death induced by overexpression of alpha-synuclein.
    Stefanova N; Klimaschewski L; Poewe W; Wenning GK; Reindl M
    J Neurosci Res; 2001 Sep; 65(5):432-8. PubMed ID: 11536327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
    Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
    Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers.
    Yamin G; Uversky VN; Fink AL
    FEBS Lett; 2003 May; 542(1-3):147-52. PubMed ID: 12729915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
    Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bicarbonate enhances alpha-synuclein oligomerization and nitration: intermediacy of carbonate radical anion and nitrogen dioxide radical.
    Andrekopoulos C; Zhang H; Joseph J; Kalivendi S; Kalyanaraman B
    Biochem J; 2004 Mar; 378(Pt 2):435-47. PubMed ID: 14640973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a partially folded intermediate in alpha-synuclein fibril formation.
    Uversky VN; Li J; Fink AL
    J Biol Chem; 2001 Apr; 276(14):10737-44. PubMed ID: 11152691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells.
    Matsuzaki M; Hasegawa T; Takeda A; Kikuchi A; Furukawa K; Kato Y; Itoyama Y
    Brain Res; 2004 Apr; 1004(1-2):83-90. PubMed ID: 15033422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
    Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
    Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
    Krishnan S; Chi EY; Wood SJ; Kendrick BS; Li C; Garzon-Rodriguez W; Wypych J; Randolph TW; Narhi LO; Biere AL; Citron M; Carpenter JF
    Biochemistry; 2003 Jan; 42(3):829-37. PubMed ID: 12534296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis.
    Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A
    Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nitration on the structure and aggregation of alpha-synuclein.
    Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
    Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
    Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
    Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC
    Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.
    Hashimoto M; Hsu LJ; Xia Y; Takeda A; Sisk A; Sundsmo M; Masliah E
    Neuroreport; 1999 Mar; 10(4):717-21. PubMed ID: 10208537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.